Renal and vascular effects of combined SGLT2 and angiotensin-converting enzyme inhibition
Lytvyn Y, Kimura K, Peter N, et al.
Circulation. 2022;0:10.1161
Leggi
Lytvyn Y, Kimura K, Peter N, et al.
Circulation. 2022;0:10.1161
Leggi
Redondo MJ, Gignoux CR, Dabelea D, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00159-0
Leggi
Chaar D, Dumont BL, Vulesevic B, et al.
Am J Cardiol. 2022;S0002-9149(22)00586-0
Leggi
Jhaveri CD, Glassman AR, Ferris FL, et al.
N Engl J Med. 2022 Jul 14
Leggi
Gupta J, Antal Z, Mauer E, et al.
BMC Endocr Disord. 2022 Jul 16;22(1):180
Leggi
Attar R, Wu A, Wojdyla D, et al.
Am J Cardiol. 2022;S0002-9149(22)00579-3
Leggi
Manisha AM, Shangali AR, Mfinanga SG, Mbugi EV
BMC Endocrine Disorders. 2022;22(1):175
Leggi
Pitocco D, Laurenzi A, Tomaselli L, et al.
NMCD. Published online, 14 July 2022
Leggi
Khunti K, Aroda VR, Bhatt DL, et al.
Diabetes Obes Metab. 2022, Jul 8
Leggi
Zou X, Huang Q, Luo Y
Diabetologia. 2022 Jul 8. Online ahead of print
Leggi